Article info
PDFTherapeutics
Randomised controlled trial
Postpartum bleeding is reduced with sublingual powdered misoprostol when compared with oxytocin injection, but a new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care
- Correspondence to: Beverly Winikoff
Gynuity Health Projects, 15 East 26th Street, New York, NY 10010, USA; bwinikoff{at}gynuity.org
Citation
Postpartum bleeding is reduced with sublingual powdered misoprostol when compared with oxytocin injection, but a new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care
Publication history
- First published November 2, 2012.
Online issue publication
February 13, 2020
Article Versions
- Previous version (13 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions